Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Inari Medical, Inc. (NARI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 8-K Quarterly results
05/19/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
02/27/2023 8-K Quarterly results
Docs: "Consolidated Statements of Operations and Comprehensive Income Three Months Ended December 31, Years Ended December 31, 2022 2021 2022 2021 Revenue $ 107,771 $ 83,218 $ 383,471 $ 276,984 Cost of goods sold 13,128 8,280 44,506 24,757 Gross profit 94,643 74,938 338,965 252,227 Operating expenses Research and development 20,412 18,726 74,221 51,018 Selling, general and administrative 80,122 54,466 292,843 190,365 Total operating expenses 100,534 73,192 367,064 241,383 income from operations 1,746 10,844 Other income Interest income 970 24 1,852 154 Interest expense Change in fair value of warrant liabilities — — — — Other income 187 356 Total other income 1,083 1,914 income before income taxes 1,681 10,685 Provision for income taxes 990 574 3,082 845 Net income $ $ 1,107 $ $ 9,840 Other c..."
01/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "GENERAL RELEASE 1. Release. For valuable consideration, the receipt and adequacy of which are hereby acknowledged, the undersigned does hereby release and forever discharge the “Releasees” hereunder, consisting of Inari Medical, Inc., a Delaware corporation , and the Company’s partners, subsidiaries, associates, affiliates, successors, heirs, assigns, agents, directors, officers, employees, representatives, lawyers, insurers, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, losses, costs, attorneys’ fees or expenses, of any nature whatsoever, known or un..."
01/10/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:"
12/19/2022 8-K Quarterly results
11/02/2022 8-K Quarterly results
09/20/2022 8-K Investor presentation
Docs: "Presentation of Inari Medical, Inc., dated September 2022",
"Presentation of Inari Medical, Inc., dated September 2022"
08/03/2022 8-K Quarterly results
08/03/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
03/15/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, by and among Inari Medical, Inc. and BofA Securities, Inc. and Morgan Stanley & Co. LLC, as representatives of the several underwriters named therein",
"Opinion of Latham & Watkins LLP"
03/01/2022 8-K Quarterly results
02/23/2022 8-K Quarterly results
Docs: "Consolidated Statements of Operations and Comprehensive Income Three Months Ended December 31, Years Ended December 31, 2021 2020 2021 2020 Revenue $ 83,218 $ 48,610 $ 276,984 $ 139,670 Cost of goods sold 8,280 3,685 24,757 13,106 Gross profit 74,938 44,925 252,227 126,564 Operating expenses Research and development 18,726 6,536 51,018 18,399 Selling, general and administrative 54,466 31,393 190,365 89,746 Total operating expenses 73,192 37,929 241,383 108,145 Income from operations 1,746 6,996 10,844 18,419 Other income 0 Interest income 24 75 154 484 Interest expense Change in fair value of warrant liabilities — — — Other expense, net Total other expenses Income before income taxes 1,681 6,985 10,685 13,789 Provision for income taxes 574 — 845 — Net income $ 1,107 $ 6,985 $ 9,840 ..."
01/10/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:"
11/09/2021 8-K Quarterly results
Docs: "Condensed Consolidated Statements of Operations and Comprehensive Income Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue $ 72,916 $ 38,715 $ 193,766 $ 91,059 Cost of goods sold 7,040 3,228 16,477 9,420 Gross profit 65,876 35,487 177,289 81,639 Operating expenses Research and development 12,499 5,217 32,292 11,863 Selling, general and administrative 56,104 23,080 135,899 58,353 Total operating expenses 68,603 28,297 168,191 70,216 income from operations 7,190 9,098 11,423 Other income Interest income 27 208 130 409 Interest expense Change in fair value of warrant liabilities — — — Other income 30 Total other expenses income before income taxes 6,496 9,004 6,804 Provision for income taxes 61 — 271 — Net income $ $ 6,496 $ 8,733 $ 6,804 Other..."
10/01/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Investor Contact:"
08/10/2021 8-K Quarterly results
06/22/2021 8-K Quarterly results
05/28/2021 8-K Quarterly results
05/24/2021 8-K Quarterly results
05/11/2021 8-K Quarterly results
03/31/2021 8-K Quarterly results
03/09/2021 8-K Quarterly results
01/13/2021 8-K Quarterly results
11/18/2020 8-K Other Events
11/12/2020 8-K Quarterly results
Docs: "Inari Medical Reports Third Quarter 2020 Financial Results"
10/22/2020 8-K Other Events
10/13/2020 8-K Quarterly results
09/17/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Inari Medical Announces Promotion of Drew Hykes to Chief Operating Officer"
09/11/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Loan, Guaranty and Security Agreement, by and among Inari Medical, Inc., Inari Medical International, Inc. and Bank of America, N.A"
08/11/2020 8-K Quarterly results
05/28/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : May 27, 2020 INARI MEDICAL, INC. Delaware 001-39293 45-2902923 9 Parker, Suite 100 Irvine, CA 92618 923-4747 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Secu...",
"Amended and Restated Certificate of Incorporation of Inari Medical, Inc",
"Amended and Restated Bylaws of Inari Medical, Inc"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy